These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 12612295

  • 1. Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma.
    Price DB, Hernandez D, Magyar P, Fiterman J, Beeh KM, James IG, Konstantopoulos S, Rojas R, van Noord JA, Pons M, Gilles L, Leff JA, Clinical Outcomes with Montelukast as a Partner Agent to Corticosteroid Therapy (COMPACT) International Study Group.
    Thorax; 2003 Mar; 58(3):211-6. PubMed ID: 12612295
    [Abstract] [Full Text] [Related]

  • 2. Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma.
    Vaquerizo MJ, Casan P, Castillo J, Perpiña M, Sanchis J, Sobradillo V, Valencia A, Verea H, Viejo JL, Villasante C, Gonzalez-Esteban J, Picado C, CASIOPEA (Capacidad de Singulair Oral en la Prevencion de Exacerbaciones Asmaticas) Study Group.
    Thorax; 2003 Mar; 58(3):204-10. PubMed ID: 12612294
    [Abstract] [Full Text] [Related]

  • 3. Effects of montelukast compared to double dose budesonide on airway inflammation and asthma control.
    Barnes N, Laviolette M, Allen D, Flood-Page P, Hargreave F, Corris P, O'Connor B, Tate H, Parker D, Pavord I.
    Respir Med; 2007 Aug; 101(8):1652-8. PubMed ID: 17481879
    [Abstract] [Full Text] [Related]

  • 4. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial.
    Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening AP, Haahtela T, Holgate ST, Picado C, Menten J, Dass SB, Leff JA, Polos PG.
    BMJ; 2003 Oct 18; 327(7420):891. PubMed ID: 14563743
    [Abstract] [Full Text] [Related]

  • 5. Montelukast: a review of its therapeutic potential in persistent asthma.
    Jarvis B, Markham A.
    Drugs; 2000 Apr 18; 59(4):891-928. PubMed ID: 10804041
    [Abstract] [Full Text] [Related]

  • 6. Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.
    Fish JE, Israel E, Murray JJ, Emmett A, Boone R, Yancey SW, Rickard KA.
    Chest; 2001 Aug 18; 120(2):423-30. PubMed ID: 11502639
    [Abstract] [Full Text] [Related]

  • 7. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening A, Haahtela T, Holgate ST, Picado C, Leff JA.
    Respir Med; 2000 Jun 18; 94(6):612-21. PubMed ID: 10921768
    [Abstract] [Full Text] [Related]

  • 8. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group.
    Malmstrom K, Rodriguez-Gomez G, Guerra J, Villaran C, Piñeiro A, Wei LX, Seidenberg BC, Reiss TF.
    Ann Intern Med; 1999 Mar 16; 130(6):487-95. PubMed ID: 10075616
    [Abstract] [Full Text] [Related]

  • 9. Double-blind, randomised, controlled trial assessing controller medications in asthma.
    Shah AR, Sharples LD, Solanki RN, Shah KV.
    Respiration; 2006 Mar 16; 73(4):449-56. PubMed ID: 16407639
    [Abstract] [Full Text] [Related]

  • 10. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group.
    Reiss TF, Chervinsky P, Dockhorn RJ, Shingo S, Seidenberg B, Edwards TB.
    Arch Intern Med; 1998 Jun 08; 158(11):1213-20. PubMed ID: 9625400
    [Abstract] [Full Text] [Related]

  • 11. Treatment with 400 microg of inhaled budesonide vs 200 microg of inhaled budesonide and oral montelukast in children with moderate persistent asthma: randomized controlled trial.
    Jat GC, Mathew JL, Singh M.
    Ann Allergy Asthma Immunol; 2006 Sep 08; 97(3):397-401. PubMed ID: 17042148
    [Abstract] [Full Text] [Related]

  • 12. Addition of formoterol or montelukast to low-dose budesonide: an efficacy comparison in short- and long-term asthma control.
    Ceylan E, Gencer M, Aksoy S.
    Respiration; 2004 Sep 08; 71(6):594-601. PubMed ID: 15627870
    [Abstract] [Full Text] [Related]

  • 13. Comparative efficacy of once-daily therapy with inhaled corticosteroid, leukotriene antagonist or sustained-release theophylline in patients with mild persistent asthma.
    Yurdakul AS, Taci N, Eren A, Sipit T.
    Respir Med; 2003 Dec 08; 97(12):1313-9. PubMed ID: 14682413
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
    Clin Ther; 2008 Aug 08; 30(8):1492-504. PubMed ID: 18803991
    [Abstract] [Full Text] [Related]

  • 15. Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast/Beclomethasone Additivity Group.
    Laviolette M, Malmstrom K, Lu S, Chervinsky P, Pujet JC, Peszek I, Zhang J, Reiss TF.
    Am J Respir Crit Care Med; 1999 Dec 08; 160(6):1862-8. PubMed ID: 10588598
    [Abstract] [Full Text] [Related]

  • 16. Addition of montelukast versus double dose of inhaled budesonide in moderate persistent asthma.
    Yildirim Z, Ozlu T, Bulbul Y, Bayram H.
    Respirology; 2004 Jun 08; 9(2):243-8. PubMed ID: 15182276
    [Abstract] [Full Text] [Related]

  • 17. Montelukast vs. inhaled low-dose budesonide as monotherapy in the treatment of mild persistent asthma: a randomized double blind controlled trial.
    Kumar V, Ramesh P, Lodha R, Pandey RM, Kabra SK.
    J Trop Pediatr; 2007 Oct 08; 53(5):325-30. PubMed ID: 17623754
    [Abstract] [Full Text] [Related]

  • 18. Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness.
    Green RH, Brightling CE, McKenna S, Hargadon B, Neale N, Parker D, Ruse C, Hall IP, Pavord ID.
    Eur Respir J; 2006 Jun 08; 27(6):1144-51. PubMed ID: 16455831
    [Abstract] [Full Text] [Related]

  • 19. Spotlight on montelukast in asthma in children 2 to 14 years of age.
    Muijsers RB, Noble S.
    Am J Respir Med; 2002 Jun 08; 1(3):225-8. PubMed ID: 14720060
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of low-dose fluticasone propionate compared with montelukast for maintenance treatment of persistent asthma.
    Meltzer EO, Lockey RF, Friedman BF, Kalberg C, Goode-Sellers S, Srebro S, Edwards L, Rickard K, Fluticasone Propionate Clinical Research Study Group.
    Mayo Clin Proc; 2002 May 08; 77(5):437-45. PubMed ID: 12004993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.